Find a Clinical Trial | Pfizer Clinical Trials

Join PfizerLink — a clinical research registry

Get notified about clinical trials that may be right for you — now and over time. Share some information about your health and medical areas of interest. We’ll reach out if a Pfizer clinical trial may be a fit.

Sickle Cell Disease clinical trial

The DREAM study is exploring whether a study medicine can reduce symptoms and improve the overall health of people with Sickle Cell Disease.

Get started

19 trials found for solid tumor

3 trials recruiting

Pfizer Breast Cancer Clinical Trials

Pfizer has several study medicines in development that may have the potential to help people with various types of breast cancer.

Recruiting

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

Melanoma, Non-Small-Cell Lung Cancer, Thyroid Cancer, Glioma

A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors

Neoplasms, Non-small-cell Lung Cancer, Melanoma, Squamous Cell Carcinoma of the Head and Neck, Renal Cell Carcinoma, Urothelial Carcinoma, Colorectal Carcinoma, Ovarian Carcinoma

A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors

Cutaneous Melanoma, Non-small Cell Lung Cancer, Colorectal Neoplasms, Pancreatic Neoplasms, Mesothelioma

A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors

Breast Cancer, Solid Tumors

A Study in Advanced/Metastatic Solid Tumors With the Study Medicine (PF-07329640) When Given Alone or In Combination

Advanced or Metastatic Solid Tumors, Non-Small Cell Lung Cancer, Colorectal Cancer, Urothelial Cancer, Melanoma

Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors

Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Exocrine Pancreatic Cancer, Carcinoma, Squamous Cell of Head and Neck

A Study of SGN-EGFRd2 in Advanced Solid Tumors

Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of the Head and Neck, Pancreatic Ductal Adenocarcinoma

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Stomach Neoplasms, Pancreatic Ductal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Small Cell Lung Carcinoma

A Study of Disitamab Vedotin Alone or With Other Anticancer Drugs in Solid Tumors

Breast Neoplasms, Gastroesophageal Junction Adenocarcinoma, HER2 Low Breast Neoplasms, HER2 Positive Breast Neoplasms, Stomach Neoplasms, Triple Negative Breast Neoplasms

A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2

Carcinoma, Squamous Cell of Head and Neck, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Endometrial Neoplasms

Male or Female

18+ years

31study location(s)